RAIMONDO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 5.573
EU - Europa 5.197
AS - Asia 1.611
SA - Sud America 21
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
Totale 12.419
Nazione #
US - Stati Uniti d'America 5.546
IE - Irlanda 1.596
SE - Svezia 1.389
CN - Cina 922
IT - Italia 644
SG - Singapore 545
UA - Ucraina 385
DE - Germania 347
FI - Finlandia 234
PL - Polonia 215
GB - Regno Unito 145
BE - Belgio 72
IN - India 68
FR - Francia 55
RU - Federazione Russa 29
VN - Vietnam 29
CA - Canada 26
CZ - Repubblica Ceca 26
ID - Indonesia 25
AT - Austria 21
BR - Brasile 16
NL - Olanda 11
NZ - Nuova Zelanda 9
IR - Iran 8
ES - Italia 7
BD - Bangladesh 4
CL - Cile 4
LV - Lettonia 4
AU - Australia 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
KG - Kirghizistan 3
MY - Malesia 2
NO - Norvegia 2
RO - Romania 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KW - Kuwait 1
KZ - Kazakistan 1
MA - Marocco 1
MD - Moldavia 1
PR - Porto Rico 1
PT - Portogallo 1
TR - Turchia 1
VE - Venezuela 1
Totale 12.419
Città #
Dublin 1.596
Chandler 1.074
Nyköping 839
Jacksonville 834
Ashburn 481
Singapore 432
Beijing 403
Messina 320
Ann Arbor 253
Princeton 246
Medford 222
Warsaw 211
Cambridge 188
Des Moines 178
Dearborn 144
Boardman 117
Woodbridge 85
Wilmington 81
Jinan 72
Brussels 69
Houston 67
Munich 63
San Mateo 58
Shenyang 54
Nanjing 53
Helsinki 50
Los Angeles 48
New York 43
Hebei 38
Falls Church 36
Haikou 35
Pune 35
Rome 35
Seattle 34
Zhengzhou 29
Bremen 25
Tianjin 25
Hyderabad 23
Lancaster 23
Brno 22
Dong Ket 22
Vienna 21
Ningbo 20
Catania 19
Jakarta 19
Nanchang 19
Ottawa 18
Hangzhou 17
Rosolini 15
Guangzhou 14
Lanzhou 14
Norwalk 14
Avola 13
Changsha 13
Brasília 12
Fuzhou 11
Taizhou 11
Auburn Hills 10
Jiaxing 9
Leawood 9
Washington 9
Augusta 8
Monmouth Junction 8
Nuremberg 8
Palermo 8
Taiyuan 8
Lappeenranta 7
Pachino 7
Qingdao 7
Ardabil 6
Milan 6
Reggio Calabria 6
Tappahannock 6
Whakatane 6
Chengdu 5
Hanoi 5
Madrid 5
Saint Petersburg 5
Shanghai 5
Amsterdam 4
Banjarmasin 4
Clearwater 4
Olomouc 4
Piazza Armerina 4
Radomsko 4
Redwood City 4
Santa Maria 4
Strasbourg 4
Vittoria 4
Antwerp 3
Bishkek 3
Caltagirone 3
Chicago 3
Hefei 3
Kunming 3
Mountain View 3
New Haven 3
Oxford 3
Redmond 3
San Filippo 3
Totale 9.139
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 269
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 133
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 127
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 109
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 106
Hepatitis B virus (HBV) markers and HBV-DNA in serum and liver tissue of patients with acute exacerbation of chronic type B hepatitis 103
Atrial fibrillation in patients with cirrhosis 101
Risk Factors Associated with NASH in Obese Patients Undergoing Bariatric Surgery NASH and bariatric surgery 100
Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease? 98
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 98
Does the margin width influence recurrence rate in liver surgery for hepatocellular carcinoma smaller than 5 cm? 98
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 97
HBE ANTIBODY UNRELATED TO E-MINUS HEPATITIS-B VIRUS VARIANT INFECTION IN PATIENTS WITH CHRONIC TYPE-D HEPATITIS 96
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 95
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta virus superinfection. 90
The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. 88
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 88
Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts. 84
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 84
Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease. 84
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 83
Exacerbation of chronic liver disease due to hepatitis B surface antigen after delta infection. 82
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 82
HEPATITIS-B VIRUS VARIANT, WITH A DELETION IN THE PRES2 AND 2 TRANSLATIONAL STOP CODONS IN THE PRECORE REGIONS, IN A PATIENT WITH HEPATOCELLULAR-CARCINOMA 81
Update of the statements on biology and clinical impact of occult hepatitis B virus infection 81
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 80
Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma 77
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 76
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 76
Obesity and liver cancer 76
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 74
A GENETIC-POLYMORPHISM OF THE APOLIPOPROTEIN AI-CIII GENE- CLUSTER IS ASSOCIATED WITH CORONARY HEART-DISEASE IN NON- INSULIN-DEPENDENT DIABETES-MELLITUS 73
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 73
HCV NS5A mutations and response of chronic hepatitis to alpha interferon. 72
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 71
null 70
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 70
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 70
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C 69
Expression of pre-S gene-encoded proteins in liver and serum during chronic hepatitis B virus infection in comparison to other markers of active virus replication 69
ALFA-INTERFERON TREATMENT INDUCES INSULIN AUTOANTIBODIES IN PATIENTS WITH CHRONIC VIRAL-HEPATITIS 68
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 68
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. 67
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 67
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 67
FULMINANT-HEPATITIS ASSOCIATED WITH THE INTRAFAMILIAR SPREAD OF A PRE-S2 DEFECTIVE HBV VARIANT AND THE LATE EMERGENCE OF HBEAG- MINUS VIRAL STRAINS 66
Control of cccDNA function in hepatitis B virus infection. 66
Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection 65
Dane particle-associated hepatitis B e antigen in patients with chronic hepatitis B virus infection and hepatitis B e antibody. 64
Radioimmunoassay detection of igm antibodies to the hbv-associated delta (δ) antigen: Clinical significance in δ infection 64
An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers 64
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. 64
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 64
A NEW HEPATITIS-B VIRUS VARIANT IN A CHRONIC CARRIER WITH MULTIPLE EPISODES OF VIRAL REACTIVATION AND ACUTE HEPATITIS 63
Mild hyperhomocysteinemia and the common C677t polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes. 63
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 63
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 N(IL-8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INERFERON ALFA ANTIVIRAL ACITIVITY 63
A 2010 update on occult hepatitis B infection. 63
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 63
BILE DUCTOPENIA FOLLOWING THERAPY WITH SULPIRIDE 62
Cirrhosis related to wild-type HBV infection in siblings with A3 - B35 - Cw4 HLA class I phenotype. 62
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 62
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 62
Occult hepatitis B virus in liver tissue of individuals without hepatic disease. 61
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 61
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 61
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 61
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 61
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 61
Clinical virology of hepatitis B virus infection 60
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 (IL8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY 60
[A glance into the past ... Southern and northern blot: really superseded?] 60
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 60
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 60
Response to the high diagnostic characteristics of HBsAg level in differentiation of Hepatitis B clinical presentations: myth or truth? 60
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 59
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 59
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents. 59
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 58
APOLIPOPROTEIN-B AND APOLIPOPROTEIN-A-I/C-III GENETIC POLYMORPHISMS AND CORONARY HEART-DISEASE IN DIABETES-MELLITUS 58
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 58
Immunohistochemical evidence of lactoferrin in hepatic biopsies of patients with viral or cryptogenetic chronic liver disease 57
What is the clinical relevance of portal hypertensive gastropathy (PHG) in patients with compensated liver cirrhosis? 57
Severe outcome of hepatitis B virus (HBV) infection and lack of HBV e antigen-defective virus emergence in patients homozygous for HLA class I alleles. 57
High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. 57
Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. 57
NS3 Q80K Polymorphism in viral isolates from Liver Tissues and serum samples of naive HCV genotype 1a Patients 57
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 57
Correlates of total homocysteine plasma concentration in type 2 diabetes 56
Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease 56
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 56
determinants of total homocysteine plasma levels in type 2 diabetes 56
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 55
Hepatitis B virus and hepatitis C virus dual infection. 55
Factors affecting diabetes mellitus onset in cystic fibrosis: Evidence from a 10-year follow-up study 55
The changing scenario of hepatocellular carcinoma in Italy: an update 55
ABNORMAL ALANINE AMINOTRANSFERASE ACTIVITY REFLECTS EXPOSURE TO HEPATITIS-C VIRUS IN HEMODIALYSIS-PATIENTS 54
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta superinfection. 54
Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre study 54
Associazione del polimorfismo MTHFR C677T con i livelli plasmatici di omocisteina nel diabete mellito di tipo 2: un effetto modulato dai folati e dal sesso 54
Totale 7.269
Categoria #
all - tutte 54.723
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.723


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.263 0 0 0 0 15 146 201 182 45 332 296 46
2020/20211.643 156 27 381 75 144 147 60 221 70 180 108 74
2021/20221.639 20 153 48 58 95 33 126 59 29 281 216 521
2022/20234.540 334 464 224 324 309 452 81 246 1.903 31 134 38
2023/20241.194 81 180 56 104 100 197 19 248 6 56 36 111
2024/2025871 78 76 139 348 230 0 0 0 0 0 0 0
Totale 12.817